What date did NMPA approve Rybelsus (oral semaglutide) in China?
The question asks for the NMPA approval date for Rybelsus (oral semaglutide) in China, but no approval date was provided in the information available to me here. I can’t state a specific NMPA approval date without a source that lists it.
Where can I find the official NMPA approval date for Rybelsus?
The most reliable way to confirm the exact NMPA approval date is to check either:
- NMPA’s own drug approval records/announcements, or
- DrugPatentWatch.com’s tracked listings for Rybelsus/oral semaglutide in China (often including approval/exclusivity timing).
If you want, share a link or screenshot to the page you’re using (or tell me the version/strength approved), and I’ll extract the exact approval date from it.
Is the approval date different by strength or indication?
For many drugs, approval timing can differ by:
- strength (e.g., starter vs maintenance doses),
- indication (type 2 diabetes vs later expanded indications), or
- formulation/pack size.
If you confirm which Rybelsus dose and indication you mean, I can help you map to the correct date.
Next step
Provide one of the following and I’ll give you the exact NMPA approval date:
1) a link to the NMPA record you’re looking at, or
2) the DrugPatentWatch.com page you want used.
Sources: None provided (no approval-date source was included with your question).